ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS)

Clinical trials for ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS) explained in plain language.

Never miss a new study

Get alerted when new ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS) trials appear

Sign up with your email to follow new studies for ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Drug safety under the microscope in korean asthma patients

Disease control Completed

This study monitored the safety and effectiveness of FASENRA, a medication for severe asthma and a related condition called EGPA, in real-world Korean patients. Doctors observed 51 adults who were starting FASENRA treatment for the first time, following them for up to 48 weeks. T…

Matched conditions: ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS)

Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS)

Get alerted when new ASTHMA, EGPA(EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS) trials appear

Drug safety under the microscope in korean asthma patients